Charles & Colvard, Ltd. (NASDAQ:CTHR)’s stock price passed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $1.59 and traded as high as $3.00. Charles & Colvard, Ltd. shares last traded at $2.98, with a volume of 187,527 shares trading hands.

Separately, Zacks Investment Research cut shares of Charles & Colvard, Ltd. from a “buy” rating to a “hold” rating in a research note on Wednesday.

The business’s 50 day moving average is $2.65 and its 200-day moving average is $1.60. The firm has a market capitalization of $89.95 million, a P/E ratio of -16.84 and a beta of 0.39. The company has a quick ratio of 3.29, a current ratio of 5.05 and a debt-to-equity ratio of 0.01.

Charles & Colvard, Ltd. (NASDAQ:CTHR) last announced its quarterly earnings data on Wednesday, February 3rd. The company reported $0.09 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.03 by $0.06. The business had revenue of $12.15 million for the quarter, compared to analysts’ expectations of $11.30 million. Charles & Colvard, Ltd. had a negative net margin of 18.62% and a negative return on equity of 0.45%. Research analysts forecast that Charles & Colvard, Ltd. will post 0.06 EPS for the current fiscal year.

In related news, Director Ollin B. Sykes bought 63,500 shares of the business’s stock in a transaction on Tuesday, March 16th. The shares were purchased at an average price of $2.79 per share, for a total transaction of $177,165.00. Following the completion of the transaction, the director now directly owns 506,314 shares of the company’s stock, valued at approximately $1,412,616.06. The acquisition was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Ollin B. Sykes bought 25,000 shares of the business’s stock in a transaction on Wednesday, February 24th. The stock was bought at an average price of $2.22 per share, for a total transaction of $55,500.00. Following the transaction, the director now directly owns 485,989 shares of the company’s stock, valued at $1,078,895.58. The disclosure for this purchase can be found here. Company insiders own 16.50% of the company’s stock.

Large investors have recently modified their holdings of the company. Carroll Financial Associates Inc. lifted its holdings in shares of Charles & Colvard, Ltd. by 11,816.7% during the first quarter. Carroll Financial Associates Inc. now owns 14,300 shares of the company’s stock worth $42,000 after purchasing an additional 14,180 shares during the period. Founders Capital Management acquired a new position in shares of Charles & Colvard, Ltd. during the fourth quarter worth $25,000. Punch & Associates Investment Management Inc. acquired a new position in shares of Charles & Colvard, Ltd. during the fourth quarter worth $214,000. Finally, Renaissance Technologies LLC lifted its holdings in shares of Charles & Colvard, Ltd. by 25.0% during the fourth quarter. Renaissance Technologies LLC now owns 2,002,468 shares of the company’s stock worth $2,463,000 after purchasing an additional 400,554 shares during the period. Institutional investors own 15.09% of the company’s stock.

Charles & Colvard, Ltd. Company Profile (NASDAQ:CTHR)

Charles & Colvard, Ltd. manufactures, markets, and distributes moissanite jewels and finished jewelries worldwide. It operates through Online Channels, and Traditional segments. The company offers stud earrings, solitaire and three stone rings, pendants, and bracelets. It also provides colorless moissanite jewel with 27 cuts and in sizes ranging from .002 carats to 6.13 carats, under the brand name Forever One, as well as gemstones under the brand name Moissanite by Charles & Colvard.

Featured Article: 52- Week Highs

Receive News & Ratings for Charles & Colvard Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Charles & Colvard Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.